Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

[1]  J. Pickup,et al.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X , 1997, Diabetologia.

[2]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[3]  D. Bluemke,et al.  Regional left ventricular function in individuals with mild to moderate renal insufficiency: the Multi-Ethnic Study of Atherosclerosis. , 2007, American heart journal.

[4]  S. Lai,et al.  Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. , 2007, Journal of the American College of Cardiology.

[5]  S. Lai,et al.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. , 2006, AJR. American journal of roentgenology.

[6]  S. Rubin,et al.  Metabolic syndrome and the risk of cardiovascular disease in older adults. , 2006, Journal of the American College of Cardiology.

[7]  T. Marwick,et al.  Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. , 2005, The American journal of cardiology.

[8]  E. Ingelsson,et al.  Novel metabolic risk factors for heart failure. , 2005, Journal of the American College of Cardiology.

[9]  E. Ingelsson,et al.  Insulin resistance and risk of congestive heart failure. , 2005, JAMA.

[10]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[11]  R. Vasan,et al.  Risk factors for heart failure. , 2004, The Medical clinics of North America.

[12]  S. Graf,et al.  Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  Nikolaidis La,et al.  Peroxisome Proliferator Activator Receptors (PPAR), Insulin Resistance, and Cardiomyopathy: Friends or Foes for the Diabetic Patient With Heart Failure? , 2004, Cardiology in review.

[14]  T. Levine,et al.  Peroxisome Proliferator Activator Receptors (PPAR), Insulin Resistance, and Cardiomyopathy: Friends or Foes for the Diabetic Patient With Heart Failure? , 2004, Cardiology in review.

[15]  W. Yin,et al.  Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. , 2004, American heart journal.

[16]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  L. Groop,et al.  Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[18]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[19]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[20]  Scott M. Williams,et al.  Race and genomics. , 2003, The New England journal of medicine.

[21]  D. Levy,et al.  Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study , 2003, Circulation.

[22]  D. Levy,et al.  Obesity and the risk of heart failure. , 2003, The New England journal of medicine.

[23]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[24]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[25]  J. Kirkpatrick.  Albuminuria and Risk of Cardiovascular Events , Death , and Heart Failure in Diabetic and Nondiabetic Individuals , 2002 .

[26]  G. Dehmer,et al.  Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. , 2001, American heart journal.

[27]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[28]  D. Mann,et al.  Cytokines as emerging targets in the treatment of heart failure. , 2000, Trends in cardiovascular medicine.

[29]  J. Gardin,et al.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.

[30]  L. Tavazzi,et al.  Clinical epidemiology of heart failure. , 1999, Congestive heart failure.

[31]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[32]  S. Anker,et al.  Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. , 1997, Journal of the American College of Cardiology.

[33]  B. Massie,et al.  Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. , 1997, American heart journal.

[34]  T. LeJemtel,et al.  Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. , 1996, Journal of the American College of Cardiology.

[35]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[36]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[37]  M. Munger,et al.  Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1996, The American journal of cardiology.

[38]  T. Kishimoto,et al.  Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Bell,et al.  Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease? , 1995, Diabetes Care.

[40]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[41]  A. Donker,et al.  Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus , 1992, The Lancet.

[42]  G. Paolisso,et al.  Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. , 1991, Metabolism: clinical and experimental.

[43]  A J Belanger,et al.  Epidemiology of heart failure. , 1991, American heart journal.

[44]  L Wilhelmsen,et al.  Risk factors for heart failure in the general population: the study of men born in 1913. , 1989, European heart journal.

[45]  S. Yusuf,et al.  Changes in Hypertension Treatment and in Congestive Heart Failure Mortality in the United States , 1989, Hypertension.

[46]  W. M. Smith.  Epidemiology of congestive heart failure. , 1985, The American journal of cardiology.

[47]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.